Welcome to Westonci.ca, your ultimate destination for finding answers to a wide range of questions from experts. Join our platform to connect with experts ready to provide accurate answers to your questions in various fields. Experience the ease of finding precise answers to your questions from a knowledgeable community of experts.
Sagot :
One of the earliest recognized human infections is tuberculosis.
Which drug has the best success rate in the treatment of tuberculosis?
- Isoniazid INH is frequently used in conjunction with the medications rifampin, pyrazinamide, and ethambutol to treat active TB.
- Even though you might start feeling better just a few weeks after starting the medication, TB treatment takes far longer than treating other bacterial infections.
- These antibiotics interfere with cell wall production and cause cell death by binding to and inhibiting the actions of penicillin binding proteins (PBPs) involved in the construction of the peptidoglycan network.
- In the genome of M, at least four significant PBPs are encoded. tuberculosis.
- Isoniazid INH is frequently used in conjunction with the medications rifampin, pyrazinamide, and ethambutol to treat active TB. Even though you might start feeling better just a few weeks after starting the medication, TB treatment takes far longer than treating other bacterial infections.
- These antibiotics interfere with cell wall production and cause cell death by binding to and inhibiting the actions of penicillin binding proteins (PBPs) involved in the construction of the peptidoglycan network.
- In the genome of M, at least four significant PBPs are encoded. tuberculosis.
To learn more about tuberclosis treat with antibiotics refer to:
https://brainly.com/question/18173152
#SPJ4
Your visit means a lot to us. Don't hesitate to return for more reliable answers to any questions you may have. Your visit means a lot to us. Don't hesitate to return for more reliable answers to any questions you may have. Get the answers you need at Westonci.ca. Stay informed with our latest expert advice.